179
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Predictive factors for flares of established stable systemic lupus erythematosus without anti-phospholipid antibodies during pregnancy

ORCID Icon, ORCID Icon, , , , & show all
Pages 3909-3914 | Received 09 Jun 2020, Accepted 26 Oct 2020, Published online: 03 Nov 2020

References

  • Clowse ME, Jamison M, Evan Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127.e1–127.e6.
  • Andreoli L, Bertsias GK, Agmon-Levin N, et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476–485
  • Onno Teng YK, Bredewold EO, Rabelink TJ, et al. An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus.Rheumatology. 2018;57(10):1707–1720.
  • . Michelle P. Pregnancy and systemic lupus erythematosus. Best Pract Res Clin Obstet Gynaecol. 2020;64:24–30.
  • Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529–556.
  • Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes.Arthritis Rheum.2005;52(2):514–521.
  • YangH, LiuH, XuD, et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares–a case control study. PLOS One. 2014;9(8):e104375.
  • Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35(6):630–640.
  • Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.
  • Itabashi K, Miura F, Uehara R, et al. New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr Int. 2014;56(5):702–708.
  • Clowse ME, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol. 2011;38(6):1012–1016.
  • Molina H. Update on complement in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol. 2002;14(5):492–497.
  • Monzavi SM, Alirezaei A, Shariati-Sarabi Z, et al. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacol. 2018;26(5):1175–1182.
  • Ishizaki J, Saito K, Nawata M, et al. Low complements and high titre of anti-sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology. 2015;54(3):405–412.
  • Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.